CytoDyn Inc. (CYDY) to Complete Development of Prostate Cancer Prognostic Test Following Close of ProstaGene Acquisition

October 26, 2018 09:17:35
  • PCaTest has already proven a superior predictive ability in comparison with other genetic prognostic tests
  • Cytodyn in the process of acquiring PCaTest developer ProstaGene and will launch a clinical study once the transaction is complete
  • Prostate cancer is the second-most common type of cancer among American men, with almost 165,000 new cases expected this year

Biotechnology company CytoDyn Inc. (OTCQB: CYDY) has unveiled a comprehensive strategy for the development of a genetic prostate cancer prognostic test ( Developed by ProstaGene, an entity that CytoDyn is in the process of acquiring, PCaTest has already demonstrated superior predictive ability in comparison to other genetic prostate cancer tests. The PCaTest employs 14 genetic biomarkers to provide an accurate prognosis of prostate cancer, with the help of a complex proprietary artificial intelligence algorithm.

Following the completion of the ProstaGene acquisition, which is expected to close during the fourth quarter of 2018, CytoDyn will initiate a…

Read More>>

More from NetworkNewsWire

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published:

NetworkNewsWire (NNW)
New York, New York
212.418.1217 Office

NetworkNewsWire has received compensation from CytoDyn Inc. for providing certain investor relations, marketing and social media services, including the preparation of this report, and expects to receive additional compensation for such services in the future. This compensation includes a monthly program fee.